In the case of CML CARD8, IL-18, and IL-1β, single-nucleotide polymorphisms (SNPs) were correlated with risk stratification and molecular response after treatment [217]. Here, IL18 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.